ClinConnect ClinConnect Logo
Search / Trial NCT05256251

Westlake Longevity Cohort

Launched by WESTLAKE UNIVERSITY · Feb 21, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gut Microbiome Aging

ClinConnect Summary

The Westlake Longevity Cohort study, also known as We-Longevity, is looking at what helps people live longer, healthier lives. This study focuses on older adults, including those aged 50 and above, living in Lishui, China. Researchers want to learn about the biological markers of healthy aging and how diet and lifestyle choices influence these markers. By gathering this information, they hope to create personalized recommendations for nutrition and lifestyle that can benefit the wider community.

To participate, you need to be at least 50 years old and plan to stay in Lishui for at least three years. However, individuals with serious health issues, like cancer or major infections, are not eligible. If you join the study, you will help researchers better understand healthy aging while also contributing to advice that could help others live better, longer lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants live in Lishui, China.
  • Participants intend to remain in Lishui for ≥3 years.
  • Exclusion Criteria:
  • Participants with infectious diseases.

About Westlake University

Westlake University is a leading research institution dedicated to advancing scientific knowledge and innovation in the life sciences. With a commitment to excellence in research and education, Westlake University engages in pioneering clinical trials that aim to explore new therapeutic interventions and improve patient outcomes. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, the university is at the forefront of transformative medical research, contributing valuable insights to the global healthcare community.

Locations

Lishui, Zhejiang, China

Lishui, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

Ju-Sheng Zheng, PhD

Principal Investigator

Westlake University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials